Arkolith/Insider Trading/MIRM/Form 4

Howe Jolanda

SVP, GLOBAL CONTROLLERMirum Pharmaceuticals, Inc. (MIRM) · full profile →Form 4 · filed Mar 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$435K
Net Open-Market Flow
-$435K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 16, 2026Sell(S)5K$91.98$435K8K
Mar 15, 2026Option exercise(M)6K——13K
Mar 15, 2026Option exercise(M)3K——7K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 15, 2026Option exercise(M)6K—$03K
Mar 15, 2026Option exercise(M)3K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001974200-26-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML